MedPath

Depression in the nursing home: Using a stepped collaborative care model to improve treatment

Not Applicable
Conditions
Depression in old age
Registration Number
DRKS00015686
Lead Sponsor
Arbeitsbereich Altersmedizin, Institut für Allgemeinmedizin der Goethe-Universität Frankfurt am Main
Brief Summary

Background Depression is the second most common psychiatric illness in older people. Its prevalence rate in nursing homes is almost twice as high as that of the older population in general; however, depression often goes unnoticed and is consequently not treated despite a good prognosis. In Germany, only around 40% of nursing home residents suffering depression receive an adequate diagnosis and only half of these receive any treatment at all (normally psychotropic medications). This glaring lack of care results in a lower quality of life, poorer physical functioning and higher mortality rates for those affected. Methods The aim of DAVOS was to develop, implement and evaluate an innovative case management concept to improve treatment of depression in nursing home residents. An initial 449 residents with and without depression were recruited for the cluster-randomized study in a stepped-wedge design (307 women (68.4%), age: M = 82.5 years (SD = 10.5)). Depression symptoms were present in 38.8% of the participants at baseline. Psychometric testing was conducted to record the outcomes (including on depressiveness, quality of life, functional level) at six assessment points. The specially qualified depression case managers from the nursing homes used a screening process developed to identify residents suffering depression and to refer them for psychotherapeutic treatment in line with their diagnosis. Results Implementation of the case management concept was successful, as is evident from the summative evaluation by the parties involved, among other indicators. Despite lack of confirmation of the main hypothesis that the intervention results in a reduction in prevalence and severity of depression, both outcomes remained relatively constant even under the negative psychosocial effects of the coronavirus pandemic. In contrast, positive tendencies were seen at the facility level, and in some cases, there were even significant improvements in depression severity (p = 0.026). A heterogeneous picture emerged with regard to secondary parameters such as quality of life, with constant to slightly positive development. Conclusion Due to massive pandemic restrictions, the overall intervention was unable to deliver its full impact at times. Nevertheless, in addition to practicable concepts to qualification for nursing home staff, DAVOS also offers important approaches to improving the care of nursing home residents in need of psychotherapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
449
Inclusion Criteria

Participants in the study must be nursing home residents that are over 60 years of age and able to give their consent to take part.

Exclusion Criteria

Exclusion criteria are an age of under 60 years, the presence of dementia, addictive disorders, bipolar disorders and other severe psychiatric diseases with the exception of depression.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Validated questionnaires and psychometric instruments that have proven their value in clinical and gerontological research are used in the face-to-face data collection interviews. The primary outcomes of DAVOS are the prevalence of depressive disorders and the manifestation of depressive symptoms (and changes therein) in the nursing home residents (measure times Baseline, T1 to T4 and Follow-up). The primary outcomes (prevalence of depressive disorders and severity of depression symptoms) will be measured using the structured clinical interview for DSM-IV (= Diagnostic and Statistical Manual of Mental Disorders) (SCID-I) and the geriatric depression scale (GDS).
Secondary Outcome Measures
NameTimeMethod
The secondary outcomes are quality of life, functional ability (instrumental activities of daily living), social participation and the type, frequency and duration of hospitalization during the observation period (also measure time Baseline, T1 to T4 and Follow-up). Established scales and instruments that have been specially developed for use in elderly populations such as the WHOQOL-OLD (WHO Quality of Life) questionnaire to investigate age-related dimensions of quality of life, or the Social and Emotional Loneliness questionnaire, will be used to measure secondary outcomes such as quality of life, functional ability and social participation. Information on the frequency and duration of hospitalizations will be taken from nursing home records.
© Copyright 2025. All Rights Reserved by MedPath